ZS Pharma, Inc.
SEC CIK 1459266 · ZSPH · last insider filing 2015-12-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Ostro Marc | Director | filed 2014 - 2015 |
| Nohra GUY P | Director | filed 2014 - 2015 |
| Whiting John M | Director | filed 2014 - 2015 |
| Akkaraju Srinivas | Director | filed 2014 - 2015 |
| Popovits Kimberly J | Director | filed 2015 - 2015 |
| Keyser D Jeffrey | Director · See Remarks | filed 2014 - 2015 |
| Babler Martin | Director | filed 2015 - 2015 |
| Alexander Robert | Director · See Remarks | filed 2014 - 2015 |
| Guillem Alvaro | Director · See Remarks | filed 2014 - 2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Rasmussen Henrik S MD | See Remarks | filed 2014 - 2015 |
| Farrow Jeffrey S | Chief Financial Officer | filed 2015 - 2015 |
| Asbury Mark | See Remarks | filed 2015 - 2015 |
| Smith Cynthia | See Remarks | filed 2014 - 2015 |
| Tomasi Adam | See Remarks | filed 2015 - 2015 |
| Creech Todd A | Chief Financial Officer | filed 2014 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.